FDA approves PFO Occluder device to reduce risk of recurrent ischemic strokes

Short resume:

patients
90%
cause
80%
blood
60%
heart
50%
FDA approves PFO Occluder device to reduce risk of recurrent ischemic strokes

The FDA approved the Amplatzer PFO Occluder device Oct. 28 to help reduce the risk of recurrent ischemic strokes in patients with patent forance ovale (PFO).
Source Cardiovascular Business
Read More…

More News

Be the first to comment

Leave a Reply

Your email address will not be published.


*